Advances in studies on autoimmune diseases treated by halofuginone.
10.19540/j.cnki.cjcmm.20170224.006
- Author:
Shi-Qi WANG
1
;
Ze-Hua DUAN
1
;
Ya-Rong ZHAO
1
;
Huan DOU
1
Author Information
1. The State Key Laboratory of Pharmaceutical Biotechnology, Medical School, Nanjing University, Nanjing 210093, China.
- Publication Type:Journal Article
- Keywords:
arthritis;
multiple sclerosis;
scleroderma;
halofuginone;
nephritis
- From:
China Journal of Chinese Materia Medica
2017;42(11):2042-2045
- CountryChina
- Language:Chinese
-
Abstract:
Halofuginone (HF) is a derivative of dichroine which is the extract of traditional Chinese medicine. It is widely used as an efficient anticoccidial drug. Recent studies have found that HF has unique biological activities, showing great potential capacities in the treatment of autoimmune diseases. In the article, we summarized the therapeutic effects of HF in a variety of autoimmune diseases and its mechanism, providing references for further clinical studies of HF.
